Common diabetes drug may lower rate of long COVID --study

Common diabetes drug linked to lower rate of long COVID Metformin is the most common type 2 diabetes drug prescribed to millions of American each year, and a new study from researchers at the National Institutes of Health (NIH) published in Diabetes Care suggests the drug can lower the risk of developing long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), in diabetics. CIDRAP

...

Metformin lowers blood sugar and is most commonly prescribed as a first-line treatment for type 2 diabetes. The drug also is prescribed off-label for weight loss and other metabolic conditions.

...